A Quinoxaline Derivative as a Potent Chemotherapeutic Agent, Alone or in Combination with Benznidazole, against Trypanosoma cruzi

BACKGROUND: Chagas’ disease is a condition caused by the protozoan Trypanosoma cruzi that affects millions of people, mainly in Latin America where it is considered endemic. The chemotherapy for Chagas disease remains a problem; the standard treatment currently relies on a single drug, benznidazole,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Jean Henrique da Silva, Ueda-Nakamura, Tânia, Corrêa, Arlene Gonçalves, Sangi, Diego Pereira, Nakamura, Celso Vataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894994/
https://www.ncbi.nlm.nih.gov/pubmed/24465654
http://dx.doi.org/10.1371/journal.pone.0085706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894994/
https://www.ncbi.nlm.nih.gov/pubmed/24465654
http://dx.doi.org/10.1371/journal.pone.0085706

Ejemplares similares